Arterial Thromboembolic Complications in Paediatric Patients

Maureen Andrew; Michelle David; Gabrielle deVeber; Lu Ann Brooker

doi:10.1055/s-0038-1657618

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(01): 715-725
DOI: 10.1055/s-0038-1657618

Disorders of hemostasis in childhood

Schattauer GmbH Stuttgart

Arterial Thromboembolic Complications in Paediatric Patients

Maureen Andrew

Hamilton Civic Hospitals Research Centre, Hamilton, ON, Canada

,

Michelle David

Hamilton Civic Hospitals Research Centre, Hamilton, ON, Canada

,

Gabrielle deVeber

Hamilton Civic Hospitals Research Centre, Hamilton, ON, Canada

,

Lu Ann Brooker

Hamilton Civic Hospitals Research Centre, Hamilton, ON, Canada

› Author Affiliations

Abstract

PDF Download

PDF (377 kb)

References

References
1 Hong C, Yun Y, Choi J, Sul J, Lee K, Cha S, Hong Y, Lee H, Hong Y, Sohn K. Takayasu arteritis in Korean children: clinical report of seventy cases. Heart Vessels 1992; 07: 91-96
2 Zheng D, Fan D, Liu L. Takayasu arteritis in China: a report of 530 cases. Heart Vessels 1992; 07: 32-36
3 Wiggelinkhuizen J, Cremin B, Cywes S. Spontaneous recanalization of renal artery stenosis in childhood Takayasu arteritis: A case report. S Afr Med J 1980; 57 (03) 96-98
4 Hall T, McDiarmid S, Grant E, Boechat M, Bosulti R. False-negative duplex Doppler studies in children with hepatic artery thrombosis after liver transplantation. Am J Roentgen 1990; 154: 573-575
5 Flint E, Sumkin J, Zajko A, Bowen A. Duplex sonography of hepatic artery thrombosis after liver transplantation. Am J Roentgen 1988; 151: 481-483
6 Lerut J, Gordon R, Tzakis A, Stieber A, Iwatsuki S, Starzl T. The hepatic artery in orthotopic liver transplantation. Helvet Chir Acta 1988; 55: 367-378
7 LeBlanc J, Culham J, Chan K, Patterson M, Tipple M, Sandor G. Treatment of grafts and major vessel thrombosis with low-dose streptokinase in children. Ann Thorac Surg 1986; 41: 630-635
8 Samara E, Voss B, Pederson J. Renal arteiy thrombosis associated with elevated cyclosporine levels: A case report and review of the literature. Transplant Proc 1988; 20 (01) 119-123
9 Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985; 254: 767-769
10 Daniels S, Specker P, Capannari TE, Schwartz D, Burke M, Kaplan S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. AJDC 1987; 141: 205-207
11 Newburger J, Takahashi M, Bums J, Beiser A, Chung K, Duffy C, Glode M, Mason W, Reddy V, Sanders S. et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347
12 McFadden PM, Ochsner JL, Mills N. Management of thrombotic complications of invasive arterial monitoring of the upper extremity. J Cardiovasc Surg 1983; 24: 35-39
13 Mortensson W, Hallbook T, Lundstrom N. Percutaneous catheterization of the femoral vessels in children. II. Thrombotic occlusion of the catheterized artery: Frequency and causes. Ped Radiol 1975; 04: 01-09
14 Mortensson W. Angiography of the femoral artery following percutaneous catheterization in infants and children. Acta Radiol [Diagn] 1976; 17: 581-593
15 Freed M, Keane J, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 1974; 50: 565-569
16 Vlad P, Hohn A, Lambert EC. Retrograde arterial catheterization of the left heart. Circulation 1964; 29: 787
17 Burrows P, Benson L, Williams W, Trusler G, Coles J, Smallhorn J, Freedom R. Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children. Circulation 1990; 82 (05) 1697-1704
18 Padmanabhan J, Krovetz LJ, Varghese PJ, Mellits ED, Rowe RD. Effect of topical papaverine in preventing thrombosis following arteriotomies. A double blind study in infants and children. J Pediatr 1977; 81 (04) 792-793
19 Ino T, Benson LN, Freedom RM, Barker GA, Zipursky A, Rowe RD. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J 1988; 115: 633-639
20 Freed M, Rosenthal A, Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin. Am Heart J 1974; 87 (03) 283-286
21 Neches WH, Mullins CE, Williams RL, Vargo TA, McNamara DG. Percutaneous sheath cardiac catheterization. Am J Cardiol 1972; 30 (04) 378-384
22 Rao PS, Thapar MK, Rogers JHJ, Strong WB, Lutcher CL, Nesbit RRJ, Wray CH. Effect of intraarterial injection of heparin on the complications of percutaneous arterial catheterization in infants and children. Catheterization and Cardiovascular Diagnosis 1981; 07: 235-246
23 Stanger P, Heymann MA, Tarnoff H, Hoffman JI, Rudolph AM. Complications of cardiac catheterization of neonates, infants, and children. Circulation 1974; 50 (03) 595-608
24 Hurwitz RA, Franken EA, Girod DA. Angiographic determination of arterial patency after percutaneous catheterization in infants and small children. Circulation 1977; 56 (01) 102-105
25 Mansfield PB, Gozzaniga AB, Litwin SB. Management of arterial injuries related to cardiac catheterization in children and young adults. Circulation 1970; 42 (03) 501-507
26 Wessel DL, Keane JF, Fellows KE, Robichaud H, Lock JE. Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. Am J Cardiol 1986; 58: 347-351
27 Gagnon RM, Goudreau E, Joyal F, Morissette M, Roussin A. The role of intravenous streptokinase in acute arterial occlusions after cardiac catheterization. Catheterization and Cardiovascular Diagnosis 1985; 11 (04) 409-412
28 Kern IB. Management of children with chronic femoral artery ostruction. J Pediatr Surg 1977; 12 (01) 83-90
29 Hoar PF, Wilson RM, Mangano DT. Heparin bonding reduces thrombogenicity of pulmonary artery catheters. N Engl J Med 1980; 305: 993-995
30 O’Neill JA, Neblett WWI, Born ML. Management of major thromboembolic complications of umbilical artery catheters. J Pediatr Surg 1981; 16: 972-978
31 Neal WA, Reynolds JW, Jarvis CW, Williams HJ. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics 1972; 50: 06-13
32 Goetzman BW, Stadalnik RC, Bogren HG, Blankenship WJ, Ikeda RM, Thayer J. Thrombotic complications of umbilical artery catheters: a clinical and radiographic study. Pediatrics 1975; 56: 374
33 Olinsky A, Aitken FG, Isdale JM. Thrombus formation after umbilical arterial catheterization: an angiographic study. S Afr Med J 1975; 49: 1467-1470
34 Mokrohisky ST, Levine R, Blumhagen JB, Wesenberg RL, Simmons SA. Low positioning of umbilical artery catheters increases associated complications in newborn infants. N Engl J Med 1978; 299: 561
35 Saia OS, Rubatelli FF, D’Elia RD. et al. Clinical and aorto-graphic asessment of the complications of arterial catheterization. Eur.J Obstet 1987; 128: 169-179
36 Wesstrom G, Finnstrom O, Stenport G. Umbilical artery catheterization in newborns. I. Thromobosis in relation to catheter type and position. Acta Pediatr Scand 1979; 68: 575-581
37 Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol 1984; 11: 461-488
38 Schmidt B, Andrew M. Neonatal thrombotic disease: Prevention, diagnosis and therapy. J Pediatr 1988; 113: 407-410
39 Barnard D, Hathaway W. Neonatal thrombosis. Am J Pediatr Hematol Oncol 1979; 01: 235-244
40 Vailas G, Brouillette R, Scott J, Shkolnik A, Conway J, Wiringa K. Neonatal aortic thrombosis: recent experience. J Pediatr 1986; 109: 101-108
41 Rajani K, Goetzman B, Wennberg R, Turner E, Abildgaard C. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. Pediatrics 1979; 63: 552-556
42 Jackson J, Truog W, Watchko J, Mack L, Cyr D, Van Belle G. Efficacy of thromboresistant umbilical artery catheters in reducing aortic thrombosis and related complications. J Pediatr 1987; 110: 102-105
43 David R, Merten D, Anderson J, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Devt Pharm Therapeutics 1981; 02 (02) 117-126
44 Bosque E, Weaver L. Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant. J Pediatr 1986; 108 (01) 141-143
45 Horgan M, Bartoletti A, Polonsky S, Peters J, Manning T, Lamont B. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr 1987; 111: 774-778
46 Ankola P, Atakent Y. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993; 10 (03) 229-232
47 Lesko S, Mitchell A, Eopstein M, Louik C, Gracoia G, Shapiro S. Heparin use a risk factor for intraventricular hemorrhage in low birth weight infants. N Engl J Med 1986; 314: 1156-1160
48 Gilhooly JT, Lindenberg JA, Reynold JW. Survey of umbilical catheter practices. Clin Res 1987; 34: 142a
49 Marsh JL, King W, Barrett C, Fonkalsrud EW. Serious complications after umbilical artery catheterization for neonatal monitoring. Arch Surg 1975; 110: 1203
50 Wigger HJ, Bransilver BR, Blanc WA. Thromboses due to catheterization in infants and children. J Pediatr 1970; 76: 01
51 Downs JB, Chapman RL, Hawkins F. Prolonged radial artery catheterization. An evaluation of heparinized catheters and continous irrigation. Arch Surg 1974; 108 (05) 671-673
52 American Association of Critical Care Nurses. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: The AACN Thunder Project. Am J Crit Care 1993; 02: 03-15
53 Butt W, Shann F, McDonnell G, Hudson I. Effect of heparin concentration and infusion rate on the patency of arterial catheters. Crit Care Med 1987; 15 (03) 230-232
54 Clifton GD, Branson P, Kelly HJ, Dotson LR, Record KE, Phillips BA, Thompson JR. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency. Heart Lung 1991; 20: 115-118
55 Kulkami M, Eisner C, Ouellet D, Zeldin R. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter. CJS 1994; 37 (01) 37-42
56 Hall S, Barr W, Lie JT. Takayasu arteritis: A study of 32 North American patients. Medicine 1985; 6489-6499
57 Tech PC, Tan LK, Chia BL. Nonspecific aorto-arteritis in Singapore with special reference to hypertension. Am Hrt J 1978; 95: 683-695
58 Kohrman MH, Huttenlocher PR. Takayasu’s arteritis; A treatable cause of stroke in infancy. Pediatr Neurol 1986; 02 (03) 154-158
59 Lupi-Herrara E, Sanchez-Torres G, Marcushamer J. Takayasu’s arteritis: Clinical study of 107 cases. Am Hrt J 1977; 93: 94-103
60 Cupps TR, Fauci A. The Vasculitides. Philadelphia: Saunders 1981; pp. 107-115
61 Gupta SK, Khanna MN, Lahiri TK. Involvement of cardiac valves in Takayasu’s arteritis. Report of 7 cases. Indian Heart J 1980; 32: 148-155
62 Valdes R, Munoz R, Bracho E, Gordillo G, Velazquez L, Nieto J. Surgical complications of renal transplantation in malnourished children. Transplant Proc 1994; 26 (01) 50-51
63 Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. Transplantation 1991; 51 (02) 406-412
64 Kalicinski P, Kaminski A, Prokural A, Grenda R, Smirska E, Chrupek M, Szymczak M, Drewniak T, Ishmail H. Surgical complications after kidney transplantation in children. Transplant Proc 1994; 26 (01) 42-43
65 Sheldon CA, Churchill BM, McLorie GA, Arbus GS. Evaluation of factors contributing to mortality in pediatric renal transplant recipients. J Pediatr Surg 1992; 27 (05) 629-633
66 Broyer M, Mitsioni A, Gagnadoux MF, Fischer AM, Beurton D, Niaudet P, Habib R. Early failures of kidney transplantation: a study of 70 cases from 801 consecutive grafts performed in children and adolescents. Adv Nephrol 1993; 22: 169
67 Rodkin RS, Bookstein JJ, Heeney DJ, Davis GB. Streptokinase and transluminal angioplasty in the treatment of acutely thrombosed hemodialysis access fistulas. Radiology 1983; 149: 425-428
68 Young AT, Hunter DW, Castaneda-Zuniga WR, So SKS, Mercado S, Cardella JF, Amplaz K. Thrombosed synthetic hemodialysis access fistulas: failure of fibrinolytic therapy. Radiology 1985; 154: 639-642
69 Abejo RC, John EG, Spigos DG. Low-dose streptokinase-induced clot lysis of an occluded arteriovenous fistula. J Pediatr 1985; 106 (02) 321-323
70 Mazzaferro V, Esquivel CO, Makowka L, Belle S, Kahn D, Koneru B, Scantlebury VP, Stieber AC, Todo S, Tsaikis AG. et al. Hepatic artery thrombosis after pediatric liver transplantation. A medical or surgical event?. Transplantation 1980; 47: 971-977
71 Rela M, Muiesan P, Baker A, Mowat AP, Mieli-Vergani G, Karani J, Williams R, Heaton ND. Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation 1996; 61 (09) 1355-1357
72 Jurim O, Csete M, Gelabert HA, Millis JM, Olthoff K, Imagawa D, Shaked A, McDiarmid SV, Busuttil RW. Reduced size grafts: The solution for hepatic artery thrombosis after pediatric liver transplantation. J Ped Surg 1995; 30 (01) 533-555
73 Dunn SP, Billmire DF, Falkensein K, Vinocur CD, Myers R, Lawrence JP, Weintraub WH. Rejection after pediatric liver transplantation is not the limiting factor to survival. J Ped Surg 1994; 29 (08) 1141-1143
74 Drazan K, Shaked A, Olthoff KM, Imagawa D, Jurin O, Shackelton C, Busuttil R. Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT). Am Surg 1996; 62 (03) 237-240
75 Esquivel CO, Jaffee R, Gordon RD, Iwatsuki S, Shaw BW, Starzl TE. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis 1985; 05 (04) 369-374
76 Hashikura Y, Kawasaki S, Okumura N, Ishikawa S, Matsunami H, Ikegami T, Nakazawa Y, Makuuchi M. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 1995; 60 (10) 1109-1112
77 Legmann P, Costes V, Tudoret L, Girardot C, Hazebroucq V, Uzan E, Feiy-Lemonnier E, Bonnin A. Hepatic artery thrombosis after liver transplantation: Diagnosis with spiral CT. AJR 1995; 164 (01) 97-101
78 Sanchez-Bueno F, Robles R, Ramirez P, Acosta F, Rodriguez JM, Lujan J, Pons JA, Aguilar J, Parrilla P. Hepatic artery complications after liver transplantation. Clin Transpl 1994; 08 (04) 399-404
79 Yanaga K, Makowka L, Starzl T. Is hepatic artery thrombosis after liver transplantation really a surgical complication?. Transplant Proc 1989; 21: 3511-3513
80 Figueras J, Busquets J, Dominguez J, Sancho C, Casanovas-Taltavull T, Rafecas A, Fabregat A, Torras J, Jaurrieta E. Intra-arterial thrombolysis in the treatment of acute hepatic artery thrombosis after liver transplantation. Transplantation 1995; 59 (09) 1356-1357
81 Ritchey ML, Lally KP, Haase GM. Superior mesenteric artery injury during nephrectomy for Wilms’ tumor. J Ped Surg 1992; 27 (05) 612-615
82 Simioni P, Zanardi S, Saracino A. Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. J Med 1992; 23 (01) 61-74
83 Al Neimi K, Boulet E, Imbaud P. Thrombosede l’artere mesenterique superieure et perforation appendiculaire chez une jeune fille. Ann Chir 1990; 44 (07) 524-526
84 Talbot RW, Heppell J, Dozois RR. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145
85 Russell JYW, Newman BM. Mesenteric vascular occlusion. JR Coll Surg Edinb 1982; 27 (05) 264-268
86 Fallat RW, Tsang RC, Glueck CJ. Hypercholesterolemia and hypertriglyceridemia in children. Prev Med 1974; 03 (03) 390-405
87 Haitas B, Baker SG, Meyer TE, Joffe BI, Seftel HC. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia. Quart J Med 1990; New Series 76 (279) 731-740
88 Sprecher DL, Schaefer EJ, Kent KM, Gregg RE, Zech LA, Hoeg JM, McManus B, Roberts WC, Brewer HB. Cardio-vascular features of homozygous familial hypercholesterolemia; Analysis of 16 patients. Am J Cardiol 1984; 54 (01) 20-30
89 Goldstein J, Brown M, Stanbury JB. (eds) Metabolic Basis of Inherited Disease. New York: McGraw Hill; 1989. Chap. 48
90 Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340 (8828) 1111-1115
91 Sorensen K. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. JCI 1994; 93: 50-55
92 Hegele RA, Connelly PW, Cullen-Dean G, Rose V. Elevated plasma lipoprotein(a) associated with abnormal stress thallium scans in children with familial hypercholesterolemia. Am J Cardiol 1993; 70: 1109-1112
93 Mouratidis B. Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterlemia by single photon emission computed tomography thallium-201 scanning. Am J Cardiol 1992; 70: 1109-1112
94 Goldstein J, Brown M. The LDL receptor defect in familial hypercholesterolemia. Med Clin North Am 1982; 66 (02) 335-362
95 Rose V, Wilson G, Steiner G. Familial hypercholesterolemia: Report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterzygous sibling. J Pediatr 1982; 100 (05) 757-759
96 Williams ML. Death of a child as a result of familial hypercholesterolaemia [published erratum appears in Med J Aust 1989; 150(4): 228]. Med J Aust 1989; 150 (02) 93-94
97 Clemens P, Beisiegel U, Steinhagen-Thiessen E. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9 year old boy. Helv Paediat Acta 1986; 41 (03) 173-182
98 Hoeg JM. Familial hypercholesterolemia. What the zebra can teach us about the horse. JAMA 1994; 271 (07) 543-546
99 Leonard JV, Clarke M, Macartney FJ, Slack J. Progression of atheroma in homozygous familial hypercholesterolemia during regular plasma exchange. Lancet 1981; 02 (8250) 811
100 Guarda LA, Borrero JL. Hand and digital ischemia due to arteriosclerosis and thromboembolization in young adults: Pathologic features with clinical correlations. Mod Pathol 1990; 03 (06) 654-658
101 Janaki S, Baruah JK, Jayaram SR, Saxena VK, Sharma SH, Tulati MS. Stroke in the young: A four year study, 1968 to 1972. Stroke 1975; 06 (03) 318-320
102 Postiglione A, Nappi A, Brunetti A, Soricelli A, Rubba P, Gnasso A, Cammisa M, Frusciante V, Cortese C, Salvatore M. Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia. Atherosclerosis 1991; 90 (01) 23-30
103 Rubba A, Mercuri M, Faccenda F, Iannuzzi A, Irace C, Strisciuglio P, Gnasso A, Tang R, Andria G, Bond MG. Premature carotid atherosclerosis: Does it occur in both familial hyperchilesterolemia and homocystinuria? Ultrasound assessment of arterial intima-media thickness and blood flow velocity. Stroke 1994; 25 (05) 943-950
104 Mabuchi H. Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986; 61: 01-06
105 Haber C, Kwiterovich PO. Dyslipoproteinemia and xanthomatosis. Ped Dermatol 1984; 0l (04) 261-280
106 West RJ, Lloyd JK. Hypercholesterolemia in childhood. Adv Pediatr 1979; 26: 01-34
107 Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers G, Bromberg IL, Cerone R. et al. The natural history of homocysteinuria due to cystathionine b-synthase deficiency. Am J Hum Genet 1985; 37: 01-31
108 Wada Y, Narisawa K, Arakawa T. Infantile type of homocysteinuria with 5,10-methylenetetrahydrofolate reductase deficiency. Monogr Hum Genet 1978; 09: 140-146
109 Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methyulenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circul 1996; 93: 07-09
110 Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van OostBA, den HeijerM, Trijbels FJ, Rozen R, Blom H. Moleclar genetic analysis in mild hyperhomo-cysteinemia: A common mutation in the methylenetetra-hydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41
111 Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg LH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698
112 Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, Jungers P. Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrol Metab 1992; 18 (2-5) 196
113 Boers GHJ. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-715
114 Genest JJ. Plasma homosyteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114-1119
115 Clarke R. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155
116 Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitive assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995; 274 (13) 1049-1057
117 Dajani AS, Bison AL, Chung KL, Durack DT, Gerber H, Kaplan EK, Millard D, Randolph MF, Shulman ST, Taubert KA. et al. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990; 144: 1218-1219
118 Centre for Disease Control. Kawasaki disease-New York. MMWR 1980; 29: 61-63
119 Kato H, Koike S, Yokoyama T. Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatr 1979; 63 (02) 175-179
120 Newburger JW, Takahashi M, Bums JC. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347
121 Durongpisitkul K, Fururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatr 1995; 96 (06) 1057-1061
122 Gersony WM. Kawasaki disease: Clinical overview. Cardiol Young 1991; 01: 192-195
123 Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneuiysm in Kawasaki disease: An angiographic study. J Pediatr 1987; 111: 705-710
124 Brown J, Dunn J, Spooner E, Kirsh M. Late spontaneous disruption of a porcine xenograft mitral valve: Clinical, hemodynamic, echocardiographic, and pathologic findings. J Thorac Cardiovasc Surg 1978; 75: 606-611
125 Geha A, Laks H, Stansel HJ, Cornhill J, Kilman J, Buckley M, Roberts W. Late failure of porcine valve heterografts in children. J Thorac Cardiovasc Surg 1979; 78: 351-364
126 Silver M, Pollock J, Silver M. et al. Calcification in porcine xenograft valves in children. Am J Cardiol 1980; 45: 685-689
127 Dunn J. Porcine valve durability in children. Ann Thorac Surg 1981; 32 (04) 357-368
128 Williams WG, Pollack JC, Geiss DM, Trusler GA, Fowler RS. Experience with aortic and mitral valve replacement in children. J Thorac Cardiovasc Surg 1981; 81: 326-333
129 Miller D, Stinson E, Oyer P. et al. The durability of porcine xenograft valves and conduits in children. Circulation 1982; Suppl.I:I 66 (02) Pt.2 I172-I185
130 Odell J, Cohn L, Gallucci V. (eds). Cardiac Bioprostheses: Proceedings of the Second International Symposium. New York: Yorke Medical Books; 1982. p. 231
131 Williams D, Danielson G, McGoon D, Puga F, Mair D, Edwards W. Porcine heterograft valve replacement in children. J Thorac Cardiovasc Surg 1982; 84 (03) 446-450
132 Antunes MJ, Vanderdonck KM, Sussman MJ. Mechanical valve replacement in children and teenagers. Eur J Cardiothorac Surg 1989; 03: 222-228
133 Human DG, Joffe HS, Fraser CB, Barnard CN. Mitral valve replacement in children. J Thorac Cardiovasc Surg 1982; 83: 873-877
134 Schaffer MS, Clarke DR, Campbell DN, Madigan CK, Wiggins Jr JW, Wolfe RR. The St. Jude Medical cardiac valve and children: Role of anticoagulant therapy. J Am Coll Cardiol 1987; 09 (01) 235-239
135 Milano A, Vouhe PR, Baillot-Vernant F, Donzeau-Gouge P, Trinquet F, Roux P, Leca F, Neveux J. Late results after left-sided cardiac valve replacement in children. J Thorac Cardiovasc Surg 1986; 92: 218-225
136 Woods A, Vargas J, Berri G, Kreutzer G, Meschengieser S, Lazzari MA. Antithrombotic therapy in children and adolescents. Thromb Res 1986; 42 (03) 289-301
137 Bradley LM, Midgley FM, Watson DC. et al. Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol 1985; 56: 533-535
138 Stewart S, Cianciotta D, Alexson C, Manning J. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valves. J Thorac Cardiovasc Surg 1987; 93: 551-554
139 Spevak P, Freed M, Castaneda A, Norwood WI, Pollack P. Valve replacement in children less than 5 years of age. J Am Cardiol 1986; 08: 901-908
140 Harada Y, Imai Y, Kurosawa H, Ishihara K, Kawada M, Fukuchi S. Ten-year follow-up after valve replacement with the St. Jude Medical prosthesis in children. J Thorac Cardiovasc Surg 1990; 100: 175-180
141 El MakhloufA, Friedli B, Oberhansli I. et al. Prosthetic heart valve replacement in children. J Thorac Cardiovasc Surg 1987; 93: 80-85
142 Schaff H, Danielson G, DiDonato R, Puga F, Mair D, McGoon D. Late results after Starr-Edwards valve replacement in children. J Thorac Cardiovasc Surg 1984; 88: 583-589
143 Solymar L, Rao PS, Mardini MK, Fawzy ME, Guinn G. Prosthetic valves in children and adolescents. Am Heart J 1991; 121: 557-568
144 Borkon AM, Soule L, Reitz BA, Gott VL, Gardner TJ. Five year follow-up after valve replacement with the St. Jude Medical valve in infants and children. Circulation 1986; 74 (Suppl. 01) I-110-I-115
145 Bovill E, Soll R, Lynch M, Bhushan F, Landesman M, Freije M, Church W, McAuliffe T, Davidson K, Sadowski J. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 1993; 81 (01) 77-83
146 Schmidt B, Andrew M. Report of scientific and standardization subcommittee on neonatal hemostasis diagnosis and treatment of neonatal thrombosis. Thromb Haemostas 1992; 67 (03) 381-382
147 Sade R, Crawford FJ, Fyfe D, Stroud M. Valve protheses in children: A reassessment of anticoagulation. J Thorac Cardiovasc Surg 1988; 95 (04) 553-561
148 Serra A, McNicholas K, Olivier HJ, Boe S, Lemole G. The choice of anticoagulation in pediatric patients with the St. Jude Medical valve prostheses. J Cardiovasc Surg 1987; 28: 588-591
149 McGrath L, Gonzalez-Lavin L, Edlredge W, Colombi M, Restrepo D. Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents. Ann Thorac Surg 1987; 43: 285-287
150 LeBlanc J, Sett S, Vince D. Antiplatelet therapy in children with left-sided mechanical prostheses. Eur J Cardiothorac Surg 1993; 07: 211-215
151 Taussig H. Long-time observations on the Blalock-Taussig operation. IX. Single ventricle (with apex to the left). Johns Hopkins Med J 1976; 139 (02) 69-76
152 Truccone N, Bowman FJ, Malm J, Gersony W. Systemic-pulmonary arterial shunts in the first year of life. Circulation 1974; 49 (03) 508-511
153 Tamisier D, Vouhe P, Vernant F, Leca F, Massot C, Neveux J. Modified Blalock-Taussig shunts: Results in infants less than 3 months of age. Ann Thorac Surg 1990; 49: 797-801
154 Bjork V, Olin C, Bjarke B, Thoren C. Right atrial-right ventricular anastomosis for correction of tricuspid atresia. J Thorac Cardiovasc Surg 1979; 77 (03) 452-458
155 Breman FJ, Malm J, Hayes C, Gersony W. Physiological approach to surgery for tricuspid atresia. Circulation 1978; (Suppl. 01) 01-83
156 Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26 (03) 240-248
157 Jonas R, Castaneda A. Modified Fontan procedure: Atrial baffle and systemic venous to pulmonaiy arteiy anastomotic techniques. J Cardiac Surg 1988; 03: 91-96
158 du PlessisA, Chang A, Wessel D. et al. Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 1995; 12: 230-236
159 Leaker M, Benson L, Andrew MBurg, Wald IngelfingerPolin. (eds). Current Pediatric Therapy. 16th. ed. Philadelphia: Saunders; 1997. Thrombolytic Therapy.
160 Andrew M, Brooker L, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemostas 1992; 68 (03) 325-330
161 Leaker M, Massicotte MP, Brooker L, Andrew M. Thrombolytic therapy in pediatric patients: A comprehensive review of the literature. Throm Haemostas 1996; 76 (02) 132-134
162 deVeber G, Andrew M. Canadian Pediatric Ischemic Stroke Registry. [Abstract] 29th Canadian Congress of Neurological Sciences. 1994
163 Schoenberg B, Mellinger J, Schoenberg D. Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival. Neurology 1978; 28: 763-768
164 Broderick J, Talbot T, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage. J Child Neurol 1993; 08: 250-255
165 Mannino FL, Travner DA. Stroke in neonates. J Pediatr 1983; 102: 605-610
166 Trauner DA, Chase C, Walker P, Wulfeck B. Neurologic profiles of infants and children arter perinatal stroke. Pediatr Neurol 1993; 09: 383-386
167 Bouza H, Rutherford M, Acolet D, Pennock JM, Dubowitz LM. Evolution of early hemiplegic signs in full term infants with unilateral brain lesions in the neonatal period: A prospective study. Neuropediatr 1994; 25 (04) 201-207
168 Lanska M, Lanska D, Horwitz S, Aram D. Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 1991; 07: 333-341
169 Trescher W. Ischemic stroke syndromes in childhood. Pediatr Ann 1992; 21 (06) 374-382
170 Roach RS, Riela AR. (eds). Pediatric Cerebrovascular Disorders. 2nd. ed. New York: Futura; 1995
171 Wiznitzer M, Masaryk TJ. Cerebrovascular abnormalities in pediatric stroke: Assessment using parenchymal and angiographic magnetic resonance imaging. Ann Neurol 1991; 29: 585-589
172 Koelfen W, Wentz U, Freund M, Schulze C. Magnetic resonance angiography in 140 neuropediatrics patients. Pediatr Neurol 1995; 12: 31-38
173 Isler W. Stroke in childhood and adolescence. Eur Neurol 1984; 23: 421-424
174 Kay R, Sing WongK, Ling YuY. Low molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995; 333: 1588-1593
175 The National Institute of Neurological Disorders for Acute Ischemic Stroke. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 (24) 1581-1587
176 Wong VK, LeMesurier J, Franseschini R, Heikali M, Hanson R. Cerebral venous thrombosis as a cause of neonatal seizures. Pediatr Neurol 1987; 03: 235-237
177 Griesemer DA, Theodorou AA, Berg RA, Spera TD. Local fibrinolysis in cerebral venous thrombosis. Ped Neur 1994; 10 (01) 78-80
178 Horowitz M, Purdy P, Unwin H, Carstens G, Grenlee R, Hise J, Kopitnik T, Batjer H, Rollins N, Samson D. Treatment of dural sinus thrombois using selective catheterization and urokinase. Ann Neurol 1995; 38: 58-67
179 Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 1995; 108 (04) 506S-522S